Peter Lanyon

Honorary Professor

University of Nottingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Lanyon is an Honorary Professor at the University of Nottingham, UK. His recent research focuses on rheumatology and autoimmune diseases, including studies on remission rates in rheumatoid arthritis, the impact of SARS-CoV-2 on immunosuppressed populations, and the management of systemic lupus erythematosus. He has also contributed to understanding the prevalence and outcomes of rare autoimmune diseases and develops guidelines to improve patient care.

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

John D. Pauling

UNITED KINGDOM

View details

Sarah Mackie

Associate Clinical Professor

University of Leeds School of Medicine

UNITED KINGDOM

View details

Fiona Pearce

Clinical Associate Professor

University of Nottingham

UNITED KINGDOM

View details

Lucio Manenti

University of Parma

ITALY

View details

Helen Thomas

Head of Clinical Trial Statistics

NHS Blood and Transplant

UNITED KINGDOM

View details

Sam Norton

Prof at King's College London

King’s College London

UNITED KINGDOM

View details

Joseph Chilcot

King’s College London

UNITED KINGDOM

View details

Jan Halbritter

University Hospital Leipzig

GERMANY

View details

Sean Hua Lim

University of Southampton

UNITED KINGDOM

View details

Dwarakanathan Ranganathan

Associate Professor

Griffith University

AUSTRALIA

View details

Joe West

Professor of Epidemiology

University of Nottingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Lanyon

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.

Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study

Prevalence, incidence, and mortality of Raynaud’s phenomenon, Sjögren’s syndrome and scleroderma: an umbrella review of systematic reviews

GP consultations and prescribed treatments for Raynaud’s: a survey among primary Raynaud’s patients in the community

Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study.

1-year survival in haemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018.

COVID-19 infection, admission and death and the impact of corticosteroids amongst people with rare autoimmune rheumatic disease during the second wave of covid-19 in England: results from the RECORDER Project.

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.

A Phase II randomised controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).

Quality standards for the care of people with giant cell arteritis in secondary care.

The incidence of Kawasaki disease using hospital admissions data for England 2006-2021.

Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY

Antinuclear antibody (ANA) testing in primary care. The test is positive what now? A two-phase observational study of UK primary care

Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study

Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.

Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study.

Collaborators (11)

John D. Pauling

Sarah Mackie

Fiona Pearce

Lucio Manenti

Helen Thomas

Sam Norton

Joseph Chilcot

Jan Halbritter

Sean Hua Lim

Dwarakanathan Ranganathan

Joe West

Make your next move.